The estimated Net Worth of Michael J Harrington is at least $5.2 millió dollars as of 22 August 2024. Mr. Harrington owns over 3,500 units of Elanco Animal Health Inc stock worth over $1,174,241 and over the last 12 years he sold ELAN stock worth over $3,693,475. In addition, he makes $328,339 as Independent Director at Elanco Animal Health Inc.
Sign up
Mr. Harrington ELAN stock SEC Form 4 insiders trading
Michael has made over 15 trades of the Elanco Animal Health Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 3,500 units of ELAN stock worth $51,975 on 22 August 2024.
The largest trade he's ever made was exercising 24,524 units of Elanco Animal Health Inc stock on 1 February 2018 worth over $355,108. On average, Michael trades about 4,587 units every 126 days since 2013. As of 22 August 2024 he still owns at least 81,094 units of Elanco Animal Health Inc stock.
You can see the complete history of Mr. Harrington stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Harrington biography
Michael J. Harrington serves as Independent Director of the Company. Mr. Harrington served in various legal roles for Lilly, including Senior Vice President and General Counsel from 2013 until his retirement in January 2020, Vice President and Deputy General Counsel of Global Pharmaceutical Operations from 2010 to 2012 and Vice President and General Counsel, Corporate from 2004 to 2010. Mr. Harrington’s roles at Lilly have provided him with extensive business development experience, experience with regulatory agencies around the world, and experience with managing intellectual property matters globally. In addition, Mr. Harrington has global operations and leadership experience as he led one of Lilly’s operating affiliates in New Zealand, and has had other leadership roles in the Asia Pacific region. In addition, Mr. Harrington has led Lilly’s information security program, and has experience with negotiating transitional services agreements (TSAs), and experience with the oversight of implementing enterprise resource planning (ERP) systems. Mr. Harrington has also had oversight of Lilly’s enterprise risk management (ERM) program. Mr. Harrington’s experience described above, including his knowledge of Elanco and the animal health industry, provides him with the qualifications and skills to serve as a director on Elanco’s Board.
What is the salary of Michael Harrington?
As the Independent Director of Elanco Animal Health Inc, the total compensation of Michael Harrington at Elanco Animal Health Inc is $328,339. There are 11 executives at Elanco Animal Health Inc getting paid more, with Jeffrey Simmons having the highest compensation of $15,801,800.
How old is Michael Harrington?
Michael Harrington is 57, he's been the Independent Director of Elanco Animal Health Inc since 2018. There are 7 older and 21 younger executives at Elanco Animal Health Inc. The oldest executive at Elanco Animal Health Inc is R. David Hoover, 74, who is the Independent Chairman of the Board.
What's Michael Harrington's mailing address?
Michael's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.
Insiders trading at Elanco Animal Health Inc
Over the last 6 years, insiders at Elanco Animal Health Inc have traded over $1,626,280,000 worth of Elanco Animal Health Inc stock and bought 657,104 units worth $14,225,149 . The most active insiders traders include Aktiengesellschaft Bayer Wo..., Scott D.Sachem Head Capital... és R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of $14,011,833. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth $51,975.
What does Elanco Animal Health Inc do?
elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.
What does Elanco Animal Health Inc's logo look like?
Complete history of Mr. Harrington stock trades at Lilly(Eli) & Co és Elanco Animal Health Inc
Elanco Animal Health Inc executives and stock owners
Elanco Animal Health Inc executives and other stock owners filed with the SEC include:
-
Jeffrey Simmons,
President, Chief Executive Officer, Director -
Sarena Lin,
Executive Vice President, Global Marketing, Corporate Strategy and Transformation -
David Kinard,
Executive Vice President of Human Resources -
David Urbanek,
Executive Vice President - Manufacturing, Quality -
Aaron Schacht,
Executive Vice President - Innovation, Regulatory, Business Development -
Todd Young,
Chief Financial Officer, Executive Vice President -
Jeffrey N. Simmons,
Pres, CEO & Director -
Todd S. Young,
Exec. VP of Corp. Governance and Strategy & CFO -
R. David Hoover,
Independent Chairman of the Board -
Kapila Anand,
Independent Director -
Lawrence Kurzius,
Independent Director -
Michael Harrington,
Independent Director -
John Bilbrey,
Independent Director -
Denise Scots-Knight,
Independent Director -
Kirk McDonald,
Independent Director -
Deborah Kochevar,
Independent Director -
Art Garcia,
Independent Director -
Joshua Smiley,
Independent Director -
Aarti Shah,
Independent Director -
David Ricks,
Independent Director -
Carl McMillian,
Independent Director -
James Meer,
Chief Accounting Officer, Vice President -
Ramiro Cabral,
Executive Vice President - Elanco International -
Michael-Bryant Hicks,
Executive Vice President, General Counsel, Corporate Secretary -
Larbi Van Lier,
Sr. VP of Asia -
Shawn McKee,
Sr. VP of U.S. Companion Animal -
David Alan Urbanek,
Exec. VP of Manufacturing & Quality -
Ramiro Martin Cabral,
Exec. VP of Elanco International -
Racquel Harris Mason,
Exec. VP & Chief Marketing Officer -
Marcela A. Kirberger,
Exec. VP, Gen. Counsel & Corp. Sec. -
Tiffany Ann Kanaga,
Head of Investor Relations -
David S. Kinard,
Exec. VP of HR Corp. Affairs & Admin. -
Chris Keeley,
Sr. VP & Chief Information Officer -
James M. Meer,
VP & Chief Accounting Officer -
De Simas Jose Manuel Correia,
SEE REMARKS -
Lilly & Co Eli,
10% owner -
Timothy J Bettington,
SEE REMARKS -
Aktiengesellschaft Bayer Wo...,
-
Racquel Harris Mason,
See Remarks -
Dirk Ehle,
Ex VP & Pres Elanco Europe -
Joyce J. Lee,
Ex VP Prs US Pet Hlth Com Op -
Rajeev A. Modi,
SEE REMARKS -
Paul Herendeen,
-
Marcela A. Kirberger,
SEE REMARKS -
William F Doyle,
-
Scott D.Sachem Head Capital...,
-
Brabander Ellen De,
SEE REMARKS -
Shiv O'neill,
GC AND CORP SEC -
Grace Mc Ardle,
EVP, MANUFACTURING AND QUALITY